- Home
- LENZ vs IAF Comparison
LENZ vs IAF Comparison
Compare LENZ & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | IAF |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.8M | 121.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LENZ | IAF |
|---|---|---|
| Price | $4.04 | $12.36 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 41.3K |
| Earning Date | 10-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $125.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $11.76 |
| 52 Week High | $32.13 | $14.54 |
Technical Indicators
Market Signals| Indicator | LENZ | IAF |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 43.13 |
| Support Level | $3.60 | $12.27 |
| Resistance Level | $6.11 | $12.80 |
| Average True Range (ATR) | 0.38 | 0.18 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 77.71 | 0.00 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About IAF abrdn Australia Equity Fund Inc.
Abrdn Australia Equity Fund Inc is a non-diversified closed-end management investment company. The Fund's principal investment objective is long-term capital appreciation through investment in equity securities of Australian companies listed on the Australian Stock Exchange Limited (ASX). Its secondary objective is current income, which is expected to be derived from dividends and interest on Australian corporate and governmental securities.